Patents by Inventor Patricia A. Okubara

Patricia A. Okubara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030131376
    Abstract: The invention is directed to nucleic acid sequences derived from Fusarium fungal genes which encode the cell wall-degrading enzymes glucanase, endochitinase, and exochitinase; isolated polypeptides having glucanase, endochitinase or exochitinase activity; recombinant nucleic acid molecules, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides, including expression in plant cells to confer or enhance a plant's resistance to Fusarium and other pathogens.
    Type: Application
    Filed: December 10, 2002
    Publication date: July 10, 2003
    Inventors: Patricia A. Okubara, Ann E. Blechl, Thomas M. Hohn, Randy M. Berka
  • Patent number: 6521435
    Abstract: The invention is directed to nucleic acid sequences derived from Fusarium fungal genes which encode the cell wall-degrading enzymes glucanase, endochitinase, and exochitinase; isolated polypeptides having glucanase, endochitinase or exochitinase activity; recombinant nucleic acid molecules, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides, including expression in plant cells to confer or enhance a plant's resistance to Fusarium and other pathogens.
    Type: Grant
    Filed: August 28, 2000
    Date of Patent: February 18, 2003
    Assignees: The United States of America as represented by the Secretary of Agriculture, Novozymes Biotech, Inc.
    Inventors: Patricia A. Okubara, Ann E. Blechl, Thomas M. Hohn, Randy M. Berka
  • Patent number: 4670399
    Abstract: Recombinant plasmids adopted for transformation of prokaryotic and eukaryotic hosts having an insertion site for at least one DNA fragment are provided. In a preferred embodiment, nucleotide sequences coding for methotrexate-resistant dehydrofolate reductase and a nucleotide sequence, a portion thereof coding for a promoter, are ligated into the insertion site.
    Type: Grant
    Filed: August 18, 1983
    Date of Patent: June 2, 1987
    Assignee: Stauffer Chemical Co.
    Inventors: Patricia A. Okubara, Dorothy A. Pierce, Robert C. Nutter